Literature DB >> 8447173

Epidemiology of Haemophilus influenzae type b disease in France.

P Reinert1, A Liwartowski, H Dabernat, C Guyot, J Boucher, C Carrere.   

Abstract

Results are reported of an epidemiological study which spanned ten years and was carried out in two French departments. A total of 277 cases of Hib disease occurring in children < 5 years old are reported and, in this age group, the incidence is evaluated at 21/100,000. Meningitis accounted for 64% of infections and epiglottitis for 7%. While the overall mortality rate was 3.3%, death was secondary to meningitis in 7/8 cases. Sequelae, which were all related to meningitis, were major in 1.2% of cases, severe in 9% of cases, and involved some hearing loss in 3.3% of cases. The monitoring networks set up in the two departments were characterized by sensitivities of 87 and 94%, respectively. They should prove useful in assessing the impact of vaccination, when large-scale implementation of vaccination has spread to both departments.

Entities:  

Mesh:

Year:  1993        PMID: 8447173     DOI: 10.1016/0264-410x(93)90158-t

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants.

Authors:  Ulla Kou Griffiths; Andrew Clark; Rana Hajjeh
Journal:  J Pediatr       Date:  2013-07       Impact factor: 4.406

2.  Haemophilus influenzae vaccines for infants in Spain.

Authors:  E Perez-Trallero; J L Diaz de Tuesta; C Gutierrez; L Gaztelorrutia
Journal:  BMJ       Date:  1995-07-29

Review 3.  Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates.

Authors:  H Peltola
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

4.  Incidence and etiological agents of bacterial meningitis among children <5 years of age in two districts of Romania.

Authors:  V Luca; B D Gessner; C Luca; T Turcu; S Rugina; C Rugina; M Ilie; E Novakova; C Vlasich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-26       Impact factor: 3.267

5.  Invasive Haemophilus influenzae disease: an ecological study of sociodemographic risk factors before and after the introduction of Hib conjugate vaccine.

Authors:  Babatunde Olowokure; Nicholas J Spencer; Jeremy I Hawker; Iain Blair; Ralph L Smith
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

6.  Comparative economic evaluation of Haemophilus influenzae type b vaccination in Belarus and Uzbekistan.

Authors:  Ulla K Griffiths; Andrew Clark; Veronika Shimanovich; Irina Glinskaya; Dilorom Tursunova; Lucia Kim; Liudmila Mosina; Rana Hajjeh; Karen Edmond
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

7.  RNA gene profile variation in peripheral blood mononuclear cells from rhesus macaques immunized with Hib conjugate vaccine, Hib capsular polysaccharide and TT carrier protein.

Authors:  Jing Tang; Ying Zhang; Xiaolong Zhang; Yun Liao; Yongrong Wang; Shengjie Ouyang; Yanchun Che; Miao Xu; Jing Pu; Qi Shen; Zhanlong He; Qiang Ye; Qihan Li
Journal:  BMC Immunol       Date:  2018-01-25       Impact factor: 3.615

8.  Invasive Haemophilus influenzae infections in Germany: impact of non-type b serotypes in the post-vaccine era.

Authors:  Helen Kalies; Anette Siedler; Britta Gröndahl; Veit Grote; Astrid Milde-Busch; Rüdiger von Kries
Journal:  BMC Infect Dis       Date:  2009-04-20       Impact factor: 3.090

9.  Meningitis registry of hospitalized cases in children: epidemiological patterns of acute bacterial meningitis throughout a 32-year period.

Authors:  Maria N Theodoridou; Vasiliki A Vasilopoulou; Erato E Atsali; Anastasia M Pangalis; Glyceria J Mostrou; Vassiliki P Syriopoulou; Christos S Hadjichristodoulou
Journal:  BMC Infect Dis       Date:  2007-08-30       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.